P2.15 Progression under Osimertinib, What Now?

Autor: Felizardo, M. 1, Sacramento, V. 1, Custódio, C. 2, Calvinho, P. 3, Madureira, R. 4, Calha, J. 5, Furtado, S. 1
Zdroj: In Journal of Thoracic Oncology November 2019 14(11) Supplement 2:S1190-S1190
Databáze: ScienceDirect